File(s) under permanent embargo
Mutations in PIK3R1 cause SHORT syndrome
journal contribution
posted on 2023-06-08, 15:25 authored by David A Dyment, Amanda C Smith, Diana AlcantaraDiana Alcantara, Jeremy A Schwartzentruber, Lina Basel-Vanagaite, Cynthia J Curry, I Karen Temple, William Reardon, Sahar Mansour, Mushfequr R Haq, Rodney Gilbert, Ordan J Lehmann, Megan R Vanstone, Chandree L Beaulieu, FORGE Canada Consortium, Jacek Majewski, Dennis E Bulman, Mark O'DriscollMark O'Driscoll, Kym M Boycott, A Micheil InnessSHORT syndrome is a rare, multisystem disease characterized by short stature, anterior-chamber eye anomalies, characteristic facial features, lipodystrophy, hernias, hyperextensibility, and delayed dentition. As part of the FORGE (Finding of Rare Disease Genes) Canada Consortium, we studied individuals with clinical features of SHORT syndrome to identify the genetic etiology of this rare disease. Whole-exome sequencing in a family trio of an affected child and unaffected parents identified a de novo frameshift insertion, c.1906_1907insC (p.Asn636Thrfs(*)18), in exon 14 of PIK3R1. Heterozygous mutations in exon 14 of PIK3R1 were subsequently identified by Sanger sequencing in three additional affected individuals and two affected family members. One of these mutations, c.1945C>T (p.Arg649Trp), was confirmed to be a de novo mutation in one affected individual and was also identified and shown to segregate with the phenotype in an unrelated family. The other mutation, a de novo truncating mutation (c.1971T>G [p.Tyr657(*)]), was identified in another affected individual. PIK3R1 is involved in the phosphatidylinositol 3 kinase (PI3K) signaling cascade and, as such, plays an important role in cell growth, proliferation, and survival. Functional studies on lymphoblastoid cells with the PIK3R1 c.1906_1907insC mutation showed decreased phosphorylation of the downstream S6 target of the PI3K-AKT-mTOR pathway. Our findings show that PIK3R1 mutations are the major cause of SHORT syndrome and suggest that the molecular mechanism of disease might involve downregulation of the PI3K-AKT-mTOR pathway.
History
Publication status
- Published
File Version
- Published version
Journal
American Journal of Human GeneticsISSN
0002-9297Publisher
ElsevierExternal DOI
Issue
1Volume
93Page range
158-166Department affiliated with
- Sussex Centre for Genome Damage Stability Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2013-07-19First Open Access (FOA) Date
2013-07-19First Compliant Deposit (FCD) Date
2013-07-19Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC